Insight Series

October 16, 2023 | 11:00 AM CT

This symposium will revisit the top abstracts from past Annual Meetings with presentations that cover post-meeting research and findings.  

Speakers

• Stefan Radtke, PhD - Fred Hutchinson Cancer Center
  Short- and Long-Term Hematopoietic Reconstitution After Transplantation is Stem Cell-driven and Stochastic: Implications for Gene Therapy 

• Peter Cook, PhD - Seattle Children's Hospital
  Generation of Islet-specific Engineered Regulatory T Cells (EngTregs) for Immune Tolerance Induction in Type 1 Diabetes Using a Novel Dual-editing Strategy

• Chang Li, PhD - University of Washington
  Correction of the Sickle Cell Mutation by In Vivo HSC Prime Editing in a Mouse Model

• Jenny Greig, PhD - Perelman School of Medicine, University of Pennsylvania
  AAV-Meganuclease-mediated Gene Targeting Achieves Efficient and Sustained
  Transduction in Newborn and Infant Macaque Liver

Watch on demand     Register now

More ASGCT Insights

Register for more sessions during ASGCT Insights Week, Oct. 16-20.

• Oct. 17: Risk Assessment of Lentiviral and AAV Gene Therapy Vectors

• Oct. 18: Risk Assessment for Gene Editing Technologies and Outcomes

• Oct. 19: Treating Genetic Diseases Prior to Birth from Stem Cells to Gene Delivery

• Oct. 20: Friend or Foe? Interplay Between Innate Immune Responses and Non-viral Gene Delivery